Novavax, Inc. is a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad read more
Stanley Erck Novavax CEO Rating
Stanley Erck Novavax CEO Rating
Novavax's CEO, Stanley Erck, has 9 employee ratings and a score of 52/100, placing them in the Bottom 10% of similar size companies on Comparably with 201-500 Employees and Bottom 5% of other companies in Washington, DC.
Where This Score Ranks Novavax's CEO Rating
- BOTTOM10%
In the Bottom 10% of 2013 Similar Sized Companies on Comparably
- BOTTOM5%
In the Bottom 5% of 221 Nearby Companies in Washington, DC
- 2nd
2nd place versus 1 competitors rated on Comparably
63
Jun
60
Dec
50
Apr
47
Jul
51
May
D-52 / 100
Jan
Novavax CEO Stanley Erck Bio
Stanley Erck serves as the CEO / President of Novavax.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at NovavaxNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at NovavaxNovavax CEO Stanley Erck At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Novavax.
Based on 9 ratings, Stanley Erck ranks right below Alnylam Pharmaceuticals' CEO, John Maraganore.
Overall, the CEO score has remained stable over the last 90 days.
Novavax CEO Stanley Erck Rating Trendline
- Novavax52
- Other Companies in Washington, DC
- Similar Size on Comparably
Novavax's CEO Rating Rank Against Similar Sized Companies on Comparably
BOTTOM
10%
Novavax ranks in the Bottom 10% of other companies on Comparably with 201-500 Employees for CEO Rating Score.
Novavax's CEO Rating Rank Against Other Companies Nearby
BOTTOM
5%
Novavax ranks in the Bottom 5% of other companies in Washington, DC for CEO Rating Score.
Anonymously Ask Novavax Any Question
Are You an Employee at Novavax?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Novavax
Related Articles
×